Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation - Sun, Q; Liu, Q; Zheng, Y; Cao, X (Mol Immunol, 2008)